Starling Medical, Inc.
Biotechnology · HOUSTON, TX
BiotechnologySEC Form D
Starling Medical, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 19, 2026, reporting $824,990 raised toward a $1,750,000 offering.
Incorporated in Delaware and based in HOUSTON, TX, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Starling Medical, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- William Andrew HendricksDirector
- Kunj ShethDirector
- Shana BarghoutiDirector
- Hannah McKenneyExecutive Officer · Director
- William HagamanDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised